Timothy M. Shannon, Director at CytomX Therapeutics, Inc. (CTMX), sold 39,887 shares at $10.43 ($416K) on 2016-05-26, disclosed to the SEC on 2016-05-27.
Open-market sale of $416k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARVN | SELL | 2021-09-27 | $4.3M | — | Filing → |
| ARVN | SELL | 2021-09-27 | $32.9M | — | Filing → |
| RLYB | BUY | 2021-08-04 | $1000K | — | Filing → |